Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Other current GTN accruals: $763M in Q2 2026, up 18.5% from a year earlier.
Latest, Q2 2026
763
Period ended Jun 28, 2026
Change on a year earlier
+18.5%
644 in Q2 2025
History
36 quarters
Since Q4 2016
Sources
35
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Note 17 — Revenue Deductions & Rebate Accruals.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Pfizer Other current GTN accruals ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/gtn-cur-other
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.